Concord is working with global biopharmaceutical companies for its fermentation and semi-synthetic complex niche API’s in the area of Immunosuppressant, antibiotic, oncology, antifungal segments and Veterinary products.
Quality is prime focus at Concord and we believe in one product-one process for the global markets, with which we have filed our DMF’s globally. Concord is known as a trusted & reliable partner for the supply API’s meeting global regulatory compliances.
Understanding Client’s need and meeting their requirement within a defined timeline is key to Concord’s success. Concord has launched several products over the years and has a robust product pipeline.
Concord has also developed and commercialized portfolio of complex and difficult to make formulations targeting the global markets. The products comprises of Oral Solids (tablets & capsules), Oral liquids and Suspensions across therapeutic segments like Immunosuppressants and Oncology range of products.
Leveraging its core competence and expertise in the area of fermentation and semi-synthesis API’s and development of complex formulations, Concord is providing services from conceptualization to commercialization to global companies as part of its Contract Research & Manufacturing business. Currently Concord is working on several NCE’s and generic products in the area of strain improvement, media optimization, scaling up process from R&D to Pilot and commercial & development of complex formulations.